Neuroscientists say they have found a new function for the SYNGAP1 gene, a DNA sequence that controls memory and learning in mammals, including mice and humans.
The finding, published in Science, may affect the development of therapies designed for children with SYNGAP1 mutations, who have a range of neurodevelopmental disorders marked by intellectual disability, autistic-like behaviors, and epilepsy.
In general, SYNGAP1, as well as other genes, control learning and memory by making proteins that regulate the strength of synapses — the connections between brain cells.
Previously, the researchers say, the SYNGAP1 gene was thought to work exclusively by encoding a protein that behaves like an enzyme, regulating chemical reactions that lead to changes in the strength of synapses. Now, the scientists say, their experiments in mice show that protein encoded by the gene may also function more like a so-called scaffolding protein that regulates synaptic plasticity, or how synapses get stronger or weaker over time, independent of its enzyme activity. The SynGAP protein appears to act as a traffic manager, they say, directing where and what brain proteins are at synapses.
SynGAP proteins are very abundant at the synapse, says the senior author, and it has long been thought that SynGAP’s main role was to spark enzymatic chemical reactions that regulate synapse strength.
But, working with the SynGAP protein, the researchers had begun to see that SynGAP proteins have a strange property when they interact with the major synaptic scaffolding protein, PSD-95. They morph into liquid droplets.
“For an enzymatic protein, that structural transformation is unusual,” says the author.
To tease out and understand the purpose of SynGAP’s peculiar liquid transformation, the team designed experiments in neurons in which they inserted mutations in the so-called GAP domain of the SYNGAP1 gene that would remove the enzymatic function of SynGAP without affecting its structure.
The team found that, even without the enzymatic activity, the synapse worked normally, suggesting that the structural property alone is very important for SynGAP function.
The research team next did the same type of genetic engineering in mice to remove the enzymatic function of SynGAP, and found similar results: Synapses behaved normally, with no problems in synaptic plasticity, and the mice had no difficulty in learning and memory behaviors. The research team says this indicates that SynGAP’s structural property was sufficient for normal cognitive behavior.
To understand how SynGAP’s structure regulates synapses, the scientists analyzed synapses more closely to find that SynGAP protein competed with the binding of AMPA receptor/TARP complexes, a bundle of neurotransmitter proteins that strengthens synapses, and the PSD-95 scaffolding protein.
The experiments suggest that, at rest, SynGAP tightly binds to PSD-95, not allowing it to bind to any other proteins in the synapse. However, during synaptic plasticity, learning and memory, SynGAP protein disconnected from PSD-95, left the synapse and allowed neurotransmitter receptor complexes to bind to PSD-95. This made the synapse stronger and increased transmission between brain cells.
“This sequence happens without the catalytic activity typical of SynGAP,” says the author. Rather, SynGAP corrals PSD-95 when bound to it, but when SynGAP leaves this synapse, PSD-95 is open to bind to AMPA receptor/TARP complexes.
In children with SynGAP mutations, about half the number of SynGAP proteins are in the synapse. With fewer SynGAP proteins, PSD-95 may bind more with the AMPA receptor/TARP complexes, changing neuronal connections and creating the increased brain cell activity characteristic of epileptic seizures common among children with SynGAP mutations.
The senior author says that both functions of SynGAP — enzymatic and the “traffic management” action of a scaffolding protein — may now be important in finding treatments for SynGAP-related neurodevelopmental disorders. Their research also suggests that targeting just one function of SynGAP alone may not be enough to have a significant impact.
Latest News
Gut-brain signaling slows f…
By newseditor
Posted 11 Sep
Epigenetic mitochondrial DN…
By newseditor
Posted 11 Sep
GlycoRNA on the cells ident…
By newseditor
Posted 11 Sep
The role of an energy-produ…
By newseditor
Posted 11 Sep
Linking gut microbial pathw…
By newseditor
Posted 10 Sep
Other Top Stories
Nobel Prize for Chemistry goes to "directed evolution of enzymes an…
Read more
Recording and storing transcriptional events!
Read more
How proteins meet on the cell membrane
Read more
Rearranging genome with CRISPR
Read more
Crystal structure of insulin bound to its receptor may make insulin…
Read more
Protocols
Fully defined NGN2 neuron p…
By newseditor
Posted 10 Sep
Clinical utility of a blood…
By newseditor
Posted 06 Sep
A glia-enriched stem cell 3…
By newseditor
Posted 01 Sep
Mouse models to investigate…
By newseditor
Posted 30 Aug
A brief guide to studying e…
By newseditor
Posted 28 Aug
Publications
Antibacterial action, prote…
By newseditor
Posted 11 Sep
Deletion of histamine H2 re…
By newseditor
Posted 11 Sep
Filopodia: integrating cell…
By newseditor
Posted 11 Sep
A homeostatic gut-to-brain…
By newseditor
Posted 11 Sep
Phosphoglycerate kinase is…
By newseditor
Posted 11 Sep
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar